Beam intensity modulation for penumbra enhancement in the treatment of lung cancer

被引:10
作者
Dirkx, MLP
Essers, M
de Koste, JRV
Senan, S
Heijmen, BJM
机构
[1] Dr Daniel Den Hoed Canc Ctr, Dept Radiat Oncol, NL-3075 EA Rotterdam, Netherlands
[2] Dr Daniel Den Hoed Canc Ctr, Div Clin Phys & Instrumentat, NL-3075 EA Rotterdam, Netherlands
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1999年 / 44卷 / 02期
关键词
penumbra enhancement; conformal radiotherapy; multileaf collimator; beam intensity modulation; lung cancer;
D O I
10.1016/S0360-3016(98)00563-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: A treatment planning study was performed for patients with lung cancer in order to investigate the extent to which doses to critical structures could be reduced by penumbra enhancement at the superior and inferior field edges, using beam intensity modulation (BIM) with a multileaf collimator. By applying two independent published models for the prediction of the incidence of normal tissue complications, the potential for dose escalation without increasing the incidence of pneumonitis was estimated. Methods and Materials: For 12 patients, the standard treatment technique was compared with the BIM technique using the Cadplan 3D planning system (Varian-Dosetek). Dose distributions in the healthy lung tissue were evaluated by considering both lungs minus the tumor as one functional unit, The following parameters were compared: (i) the average normalized total dose (NTD), (ii) the lung volume receiving an NTD of more than 20 Gy, and (iii) the calculated normal tissue complication probability (NTCP), Results: Due to the applied BIM technique, the field lengths could be reduced by 1.4 cm for all patients, while achieving a minimum dose at the superior and inferior parts of the target of 95% of the isocenter dose. Compared to the standard technique, BIR;I reduced the patient mean of the average NTD for the healthy lung tissue from 16.5 to 15.3 GS, The volume of healthy lung tissue receiving an NTD of 20 Gy or more was reduced by 9.7% (range 2.2 to 23.1%). The calculated NTCP reduced from 10.7% to 7.6% on average. The length of the esophagus that received a dose of 60 Gy or more could be reduced for 5 of the 6 stage III patients in this study, Based on equal lung NTCPs for the standard technique and the BIM technique, a mean dose escalation of 5.7 Gy (range 1.1 to 16.0 Gy) was possible for the 12 patients in this study. Based on equal average NTDs for the two techniques, the patient mean of the allowed dose escalation was 6.5 Gy (range 1.1 to 18.2 Gy), All dose escalations would be possible without exceeding the spinal cord tolerance dose. Conclusions: The BIM technique reduced the dose delivery to critical tissues. Two published methods for estimating the incidence of pneumonitis both painted to a potential for dose escalation of 6 to 7 Gy on average with the BIM technique, without increasing the incidence of pneumonitis. For 2 of the 12 patients in this study the estimated allowed dose escalation even exceeded 15 Gy, (C) 1999 Elsevier Science Inc.
引用
收藏
页码:449 / 454
页数:6
相关论文
共 28 条
  • [1] [Anonymous], 1996, BRIT J RADIOLOGY S25
  • [2] EFFECT OF CHEMOTHERAPY ON LOCALLY ADVANCED NON-SMALL-CELL LUNG-CARCINOMA - A RANDOMIZED STUDY OF 353 PATIENTS
    ARRIAGADA, R
    LECHEVALIER, T
    QUOIX, E
    RUFFIE, P
    DECREMOUX, H
    DOUILLARD, JY
    TARAYRE, M
    PIGNON, JP
    LAPLANCHE, A
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (06): : 1183 - 1190
  • [3] THE INFLUENCE OF SCATTER ON THE DESIGN OF OPTIMIZED INTENSITY MODULATIONS
    CHEN, Z
    WANG, XH
    BORTFELD, T
    MOHAN, R
    REINSTEIN, L
    [J]. MEDICAL PHYSICS, 1995, 22 (11) : 1727 - 1733
  • [4] Choy H, 1995, SEMIN ONCOL, V22, P38
  • [5] A RANDOMIZED PHASE-I/II TRIAL OF HYPERFRACTIONATED RADIATION-THERAPY WITH TOTAL DOSES OF 60.0 GY TO 79.2 GY - POSSIBLE SURVIVAL BENEFIT WITH GREATER-THAN-OR-EQUAL-TO 69.6 GY IN FAVORABLE PATIENTS WITH RADIATION-THERAPY ONCOLOGY GROUP STAGE-III NON-SMALL-CELL LUNG-CARCINOMA - REPORT OF RADIATION-THERAPY ONCOLOGY GROUP 83-11
    COX, JD
    AZARNIA, N
    BYHARDT, RW
    SHIN, KH
    EMAMI, B
    PAJAK, TF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) : 1543 - 1555
  • [6] Field margin reduction using intensity-modulated x-ray beams formed with a multileaf collimator
    Dirkx, MLP
    Heijmen, BJM
    Korevaar, GA
    vanOs, MJH
    Stroom, JC
    Koper, PCM
    Levendag, PC
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (05): : 1123 - 1129
  • [7] Medically inoperable lung carcinoma: The role of radiation therapy
    Dosoretz, DE
    Katin, MJ
    Blitzer, PH
    Rubenstein, JH
    Galmarini, DH
    Garton, GR
    Salenius, SA
    [J]. SEMINARS IN RADIATION ONCOLOGY, 1996, 6 (02) : 98 - 104
  • [8] PITFALLS IN THE USE OF HIGH-ENERGY X-RAYS TO TREAT TUMORS IN THE LUNG
    EKSTRAND, KE
    BARNES, WH
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (01): : 249 - 252
  • [9] Goor C, 1996, ANN ONCOL, V7, P101
  • [10] Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer
    Graham, MV
    Purdy, JA
    Emami, B
    Matthews, JW
    Harms, WB
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (05): : 993 - 1000